Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
Amy Brennan
Advertisement
Articles by Amy Brennan
Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD
2
Counseling Patients On Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS
3
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape?
4
New Nonsteroidal Options Are Reshaping Pediatric Atopic Dermatitis Care
5